FDA warns of a nationwide recall of Lactated Ringer’s injection

The FDA says B. Braun Medical has recalled specific lots of Lactated Ringer’s Injection, 1L, after the product was found to contain particulate matter in solution. The recall was announced on April 28, 2026, and it applies to hospitals and other healthcare facilities.

For most readers, the main takeaway is simple: this is a facility-level safety issue, not a reason to stop needed care on your own. If you recently received IV fluids and are concerned, contact the treating facility or your clinician and ask whether the recalled product was used.

What the recall involves

According to the FDA, the recalled product is B. Braun’s Lactated Ringer’s Injection, E7500, 1L. The company said it identified the problem through complaints, and the affected product may contain particulate matter, including cellulose and stearates. The recall covers two lots distributed nationwide to hospitals and healthcare facilities.

The FDA’s recall notice says the company has not received reports of adverse events related to this recall so far. Even so, the agency notes that if loose particles are infused into a patient’s bloodstream, the product could potentially cause serious harm.

What particulate matter means in an IV fluid

Particulate matter means small foreign particles that do not belong in the solution. In an IV product, that matters because the fluid goes directly into the bloodstream. The FDA says foreign particles infused intravenously can contribute to blood vessel blockage, vein inflammation, immune system activation, organ dysfunction, and breakdown of blood cells.

That does not mean every exposed patient will be harmed. It does mean the product did not meet expected quality standards, which is why recalls exist: to remove defective or potentially harmful medicine before more people are exposed.

Who may be affected

The recall mainly affects hospitals, emergency departments, infusion centers, and other healthcare facilities that stocked the affected lots. Patients who recently received this specific IV fluid may have questions, especially if they were treated at a facility that uses B. Braun products.

If a facility has the recalled product on hand, it should stop using it and arrange return of the affected lots. If a patient already received an IV fluid and feels unwell, they should contact their clinician. Sudden or severe symptoms, such as trouble breathing, chest pain, fainting, or a serious reaction, should be treated as urgent or emergency symptoms.

Recall is not the same as shortage

It is easy to confuse a recall with a shortage, but they are not the same thing. The FDA says drug shortages can happen for many reasons, including manufacturing and quality problems, delays, and discontinuations. A recall is a company’s action to remove a defective product from the market or warn about a risk, while the shortage database tracks supply problems when a drug is unavailable or at risk of becoming unavailable.

That distinction matters because a recall does not automatically mean the drug is in short supply everywhere. It also does not mean every similar IV fluid product is affected.

What readers can do

Ask the hospital, clinic, or infusion center whether the recalled lot numbers were used.
If you have paperwork from a recent infusion, check whether the product name or lot number is listed.
Follow instructions from your clinician if they ask you to watch for symptoms or report problems.
Do not delay medically needed treatment without speaking with a healthcare professional.

Why FDA updates matter

The FDA’s Recalls and Shortages Branch monitors recall alerts, evaluates health risks, and coordinates with shortage staff when needed. For readers, the agency’s recall page remains the best place to check for status changes or additional details if the situation develops.

For now, the core message is straightforward: this recall is a targeted safety action, the risk is tied to specific lots, and most patients should simply confirm details with their care team if they think they may have been affected.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.